{"id":54164,"date":"2023-03-30T14:50:06","date_gmt":"2023-03-30T09:20:06","guid":{"rendered":"https:\/\/corpbiz.io\/learning\/?p=54164"},"modified":"2023-03-30T14:50:08","modified_gmt":"2023-03-30T09:20:08","slug":"regulations-for-environment-clearance-for-bulk-drugs-and-intermediates-industries","status":"publish","type":"post","link":"https:\/\/corpbiz.io\/learning\/regulations-for-environment-clearance-for-bulk-drugs-and-intermediates-industries\/","title":{"rendered":"Regulations Governing Environment Clearance for Bulk Drugs and Intermediates Industries"},"content":{"rendered":"\n<p>Bulk drug intermediate industries produce the raw\nmaterials or intermediates used to produce bulk drugs or Active Pharmaceutical\nIngredient (APIs). These industries play a crucial role in the pharmaceutical\nsupply chain by providing raw materials to manufacture finished drug products.\nThey also allow manufacturers to optimize their production processes by\noutsourcing intermediate production, reducing costs and improving efficiency. Environment\nClearance for bulk drugs is subject to strict regulations and quality\nstandards to ensure the safety and efficacy of the final drug products. The\nindustry constantly evolves as new drugs and treatments are developed, creating\nnew opportunities for intermediate manufacturers to innovate and expand their\nproduct offerings.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title ez-toc-toggle\" style=\"cursor:pointer\">Page Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/corpbiz.io\/learning\/regulations-for-environment-clearance-for-bulk-drugs-and-intermediates-industries\/#Type_of_Bulk_Drug_Intermediate_Industries\" >Type of Bulk Drug Intermediate Industries<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/corpbiz.io\/learning\/regulations-for-environment-clearance-for-bulk-drugs-and-intermediates-industries\/#Importance_of_Environment_Clearance_for_Bulk_Drugs_and_Intermediate_Industries\" >Importance of Environment Clearance for Bulk Drugs and Intermediate\nIndustries<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/corpbiz.io\/learning\/regulations-for-environment-clearance-for-bulk-drugs-and-intermediates-industries\/#Environmental_Aspects_for_Bulk_Drugs_Manufacturing_Process\" >Environmental Aspects for Bulk Drugs Manufacturing Process<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/corpbiz.io\/learning\/regulations-for-environment-clearance-for-bulk-drugs-and-intermediates-industries\/#Regulations_Governing_Environment_Clearance_for_Bulk_Drugs_and_Intermediate_Industries\" >Regulations Governing Environment Clearance for Bulk Drugs and Intermediate Industries<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/corpbiz.io\/learning\/regulations-for-environment-clearance-for-bulk-drugs-and-intermediates-industries\/#Conclusion\" >Conclusion<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Type_of_Bulk_Drug_Intermediate_Industries\"><\/span>Type of Bulk Drug Intermediate Industries<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The bulk\ndrug intermediate industry is segmented based on the intermediate and end user\ntype.<\/p>\n\n\n\n<p><strong>Type of\nIntermediate<\/strong>:<\/p>\n\n\n\n<ul><li><strong>API Intermediate<\/strong>: These\nare the raw materials or drugs responsible for the therapeutic action of the\nfinal drug product.<\/li><li><strong>Advanced Intermediate<\/strong>: These\nare advanced forms of drug intermediates used for drug interaction activity to\nform new chemical products.<\/li><\/ul>\n\n\n\n<p><strong>End User:<\/strong><\/p>\n\n\n\n<ul><li><strong>Pharmaceutical Industry<\/strong>: This\nincludes drug manufacturers and pharmaceutical companies that use the\nintermediates to manufacture finished drug products.<\/li><li><strong>Biotechnology Industry<\/strong>: This\nincludes biotech companies that use intermediates to develop biologics and\nbiosimilars.<\/li><li><strong>Chemical Industry<\/strong>: This includes\nchemical companies that produce intermediates for use in the pharmaceutical and\nbiotechnology industries and for other applications such as cosmetics and\nfragrances.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Importance_of_Environment_Clearance_for_Bulk_Drugs_and_Intermediate_Industries\"><\/span>Importance of Environment Clearance for Bulk Drugs and Intermediate\nIndustries<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The\nimportance of Environmental Clearance for bulk drugs and intermediate\nindustries are as follows:<\/p>\n\n\n\n<ul><li><strong>Helps in Environmental Impact Assessment (EIA) Study<\/strong>: To get environmental clearance for bulk drugs and intermediate industries they are required to conduct a comprehensive EIA study. The study should identify potential environmental impacts and provide recommendations for mitigating or minimizing those impacts.<\/li><li><strong>Ensures Submission of Application to SEIAA or MoEF<\/strong>: Once the EIA study is completed, the industry must apply to the State Environment Impact Assessment Authority (SEIAA) or the Ministry of Environment and Forests <strong>(MoEF)<\/strong><sup><a class=\"text-primary\" href=\"https:\/\/moef.gov.in\/en\/\"><strong>[1]<\/strong><\/a><\/sup> for obtaining environmental clearance.<\/li><li><strong>Ensures Compliance With Environmental Regulations<\/strong>: To obtain <strong><a href=\"https:\/\/corpbiz.io\/environmental-clearance\">environmental clearance<\/a><\/strong>, the industry must comply with all relevant environmental regulations and standards, including those related to air and water pollution, solid and hazardous waste management, noise pollution, and biodiversity conservation. The industry must demonstrate that it has taken all necessary measures to prevent or mitigate environmental impacts and ensure sustainable development.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Environmental_Aspects_for_Bulk_Drugs_Manufacturing_Process\"><\/span>Environmental Aspects for Bulk Drugs Manufacturing Process<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The\nenvironmental aspects that are typically associated with the bulk drug and intermediate\nindustry:<\/p>\n\n\n\n<ul><li><strong>Effluent<\/strong>: The industry generates wastewater during various stages of the production process. The effluent contains organic and inorganic compounds, heavy metals, and other contaminants that can harm the environment and human health if not treated properly.<\/li><li><strong>Emission<\/strong>: The industry also emits\nvarious gases during the production process, such as nitrogen oxides, sulfur\ndioxide, and carbon monoxide. These emissions can contribute to air pollution\nand adversely affect the local environment and public health.<\/li><li><strong>Fugitive emission<\/strong>:\nFugitive emissions refer to releasing gases or vapors from equipment or\nprocesses that are not intentionally vented to the atmosphere. This can occur\ndue to leaks or other malfunctions, and can lead to the release of harmful\nchemicals into the environment.<\/li><li><strong>Noise Pollution Aspect<\/strong>: The\nindustry can generate high noise levels due to equipment operation and other\nactivities. This can lead to noise pollution and have adverse effects on nearby\ncommunities and wildlife.<\/li><li><strong>Solid Wastes<\/strong>: The\nproduction process generates solid waste, such as packaging materials,\ncontainers, and other non-hazardous materials. Improper disposal of these\nwastes can lead to environmental pollution and health risks.<\/li><li><strong>Hazardous Wastes<\/strong>: The\nindustry also generates hazardous waste, such as chemical by products and waste\nmaterials that cannot be reused or recycled. These wastes can pose significant\nrisks to human health and the environment if improperly handled and disposed\nof.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Regulations_Governing_Environment_Clearance_for_Bulk_Drugs_and_Intermediate_Industries\"><\/span>Regulations Governing Environment Clearance for Bulk Drugs and Intermediate Industries<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The regulatory framework for obtaining\nEnvironmental Clearance (EC) for bulk drug and intermediate industries in India\nis governed by the Ministry of Environment, Forest and Climate Change (MOEFCC)\nand the State-level Environment Impact Assessment Authorities (SEIAA).<\/p>\n\n\n\n<p>The process for obtaining Environment Clearance for\nbulk drugs involves the following steps:<\/p>\n\n\n\n<ul><li><strong>Submission of An\nApplication<\/strong>: The industry seeking\nEC has to submit an application to the concerned SEIAA along with necessary\ndocuments and fees.<\/li><li><strong>Screening:<\/strong> The SEIAA conducts a screening of the application\nto ensure it is complete and all relevant information is provided.<\/li><li><strong>Scoping<\/strong>: If the application is complete, the SEIAA\nidentifies the proposed project&#8217;s potential impacts and specifies the terms of\nreference (ToR) for preparing an Environmental Impact Assessment (EIA) report.<\/li><li><strong>Preparation of EIA\nReport<\/strong>: The industry has to prepare an\nEIA report based on the ToR provided by the SEIAA. The EIA report should\ninclude an assessment of the project&#8217;s potential environmental impacts,\nmeasures to mitigate these impacts, and a plan for monitoring and reporting\nenvironmental performance.<\/li><li><strong>Public Consultation<\/strong>: The EIA report is made available to the public\nfor comments and feedback. A public hearing is also conducted to gather\nfeedback from the local community.<\/li><li><strong>Appraisal<\/strong>: The SEIAA appraises the EIA report, public\ncomments, and feedback received during the public hearing, and prepares a\nreport with its recommendations.<\/li><li><strong>Decision-Making<\/strong>: Based on the SEIAA&#8217;s report, the MOEFCC decides\non whether to grant or deny EC. If EC is granted, it is subject to conditions\nthat the industry must comply with.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span>Conclusion<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Environment Clearance for bulk drugs and intermediate industries asks for operation in an environmentally sustainable manner. The SEIAA and MOEF have laid down various regulations and guidelines to ensure the industries comply with environmental norms and standards. The industries need to assess the environmental impact of their activities and take necessary measures to mitigate any adverse effects. Strict monitoring and enforcement of regulations are also required to ensure compliance. By following these regulations and adopting cleaner production practices, the bulk drug and intermediate industries can ensure sustainable growth while safeguarding the environment and public health.<\/p>\n\n\n\n<p><strong>Also Read<\/strong>:<br><a href=\"https:\/\/corpbiz.io\/learning\/environmental-clearance-process-in-india\/\">Environmental Clearance Process In India: A Complete Outlook<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bulk drug intermediate industries produce the raw materials or intermediates used to produce bulk drugs or Active Pharmaceutical Ingredient (APIs). These industries play a crucial role in the pharmaceutical supply chain by providing raw materials to manufacture finished drug products. They also allow manufacturers to optimize their production processes by outsourcing intermediate production, reducing costs [&hellip;]<\/p>\n","protected":false},"author":52,"featured_media":54165,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[3185],"tags":[3347],"acf":{"service_id":"571"},"authorName":"Suchandra Mukherjee","authorImageUrl":"https:\/\/corpbiz.io\/learning\/wp-content\/uploads\/2023\/01\/MicrosoftTeams-image-52-1.jpg","authorDescription":"Suchandra is a 5th Year Law Student, pursuing Law from University of Mumbai. She has published 100+ Articles and Blogs on Legal Portals and International Multidisciplinary peer-reviewed journals. She is adept at legal research and can write fast SEO-friendly creative articles and blog posts on legal topics. She loves to paint and watch thriller movies in her free time.","postViews":3463,"readingTime":4,"_links":{"self":[{"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/posts\/54164"}],"collection":[{"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/users\/52"}],"replies":[{"embeddable":true,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/comments?post=54164"}],"version-history":[{"count":6,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/posts\/54164\/revisions"}],"predecessor-version":[{"id":54171,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/posts\/54164\/revisions\/54171"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/media\/54165"}],"wp:attachment":[{"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/media?parent=54164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/categories?post=54164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/corpbiz.io\/learning\/wp-json\/wp\/v2\/tags?post=54164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}